Seven Charged in Historic $100 Million California Jewelry Heist

In a significant cybersecurity incident, researchers have confirmed the leak of 16 billion login credentials, including passwords, potentially compromising services such as Apple, Facebook, Google, and various government sites. According to Forbes, the discovery involves 30 exposed datasets, each with hundreds of millions to over 3.5 billion records, unveiled since the beginning of 2025. This alarming breach is described as one of the largest in history, with experts warning that it provides a blueprint for mass exploitation. Darren Guccione, CEO of Keeper Security, emphasized the severity of the leak, stating, "This is not just a leak - it's a blueprint for mass exploitation." The compromised data presents opportunities for phishing campaigns, account takeovers, and business email compromise attacks. In light of these threats, Google has urged users to enhance their account security by adopting passkeys and moving away from traditional passwords. Passkeys utilize biometric authentication to provide safer login methods, reinforcing the need for robust security measures in the wake of such breaches.

The U.S. Food and Drug Administration (FDA) has approved lenacapavir, a groundbreaking long-acting injectable medication for HIV prevention, requiring only two doses annually. Clinical trials demonstrated that the drug reduces the risk of HIV transmission by over 99.9% in both adults and adolescents, achieving a 100% prevention rate in a study involving over 2,000 women in sub-Saharan Africa. "This is a historic day in the decades-long fight against HIV," stated Daniel O'Day, Chairman of Gilead Sciences, emphasizing the potential for lenacapavir to transform the landscape of HIV prevention. Despite its promising efficacy, concerns loom over the drug's expected high cost, estimated to reach up to $25,000 annually in the U.S. Critics, including UN officials, argue that such pricing could hinder widespread access, calling for Gilead to lower costs significantly. Previous long-acting options have faced similar accessibility challenges, limiting their global impact. Reports from The New England Journal of Medicine highlighted the robust results, alongside side effects such as injection site reactions and nausea, raising important discussions about equitable access to this breakthrough therapy.

A brain-dead pregnant woman in Georgia, Adriana Smith, has given birth after being kept alive due to the state's strict abortion laws, prompting significant public attention and debate. Officials stated that Smith's son, Chance, was delivered prematurely via emergency Cesarean section on June 13, 2025, weighing approximately 0.8 kilograms and currently receiving care in the Neonatal Intensive Care Unit (NICU). Smith was declared brain-dead in February 2025 after suffering multiple blood clots, while she was nine weeks pregnant. Due to Georgia's law banning abortions after six weeks, doctors refrained from taking action that might contravene these legal restrictions, according to her mother, April Newkirk. "This decision should've been left to us," she said, emphasizing the need for choice in such situations. Since the U.S. Supreme Court's decision to overturn Roe v. Wade in 2022, over 20 states, including Georgia, have enacted stringent abortion regulations. Congresswomen Nikema Williams, Ayanna Pressley, and Sara Jacobs are advocating for improved protections for pregnant women, particularly for Black women, who they argue face systemic medical neglect and restrictive legal environments.